New4med GmbH, a German startup specializing in cutting-edge spine treatments, has successfully launched its innovative basivertebral nerve ablation (BVNA) therapy in Europe. BVNA is a minimally invasive, implant-free procedure approved in Europe for treating vertebrogenic pain, a type of chronic low back pain caused by bony lesions in the vertebral end plates. The treatment uses targeted radiofrequency energy to block pain signals from the basivertebral nerve to the brain, with the goal of enhancing function and providing long-lasting pain relief.
According to Daniel Seifert, a shareholder and designated CEO of New4med, the company aims to make BVNA accessible to a wide range of individuals suffering from chronic low back pain in Europe. Prof. Robert Pflugmacher of Mechernich emphasized the significant potential of basivertebral nerve ablation to help those with chronic pain, expanding the treatment options in interventional chronic pain therapy. Furthermore, Prof. Andreas Kurth, a pioneer in RF technology for spinal metastases treatment, highlighted the importance of this therapy’s market launch and potential for revolutionizing current treatment methods.
New4med GmbH focuses on developing and distributing innovative products and procedures in spinal surgery to address chronic back pain and enhance patients’ quality of life. The company’s team comprises industry professionals dedicated to innovation and improving the lives of millions worldwide. New4med is committed to expanding market access and meeting the increasing demand for BVNA, setting the stage for a series of groundbreaking approaches in spine surgery.
For more information on New4med and its revolutionary BVNA therapy, please visit http://www.new4med.com. Stay updated on the latest news and developments in spinal surgery by visiting our website. The company can also be reached via the listed contact information for inquiries or additional details.
Photo – https://mma.prnewswire.com/media/2454767/New4Med.jpg
Logo – https://mma.prnewswire.com/media/2454766/New4Med_Logo.jpg
For press inquiries or to learn more about New4med’s BVNA therapy and other innovative products, please contact the designated person and visit the company’s website for additional information and resources. New4med remains committed to improving the quality of life for individuals experiencing chronic back pain through cutting-edge spinal surgery treatments and advancements.
Source link
